BIONEUTRAL

BIO P/E Ratio Analysis

33.5x

Higher than 69% of Healthcare sector peers

Updated 413h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 33.5x means investors pay $33.50 for every $1 of the company's trailing earnings, a common valuation yardstick.

Sector Performance

69th percentile

BIO

33.5x

Sector Median

28.5x

Sector Avg

35.3x

Prior Period

45.7x(Jul 2026)

↑ Improving

📊

Deep Analysis

The P/E ratio of 33.5x means investors pay $33.50 for every $1 of the company's trailing earnings, a common valuation yardstick.

This is above the healthcare sector median of 28.5x, placing Bio-Rad in the 69th percentile of its peer group. The year-over-year change is N/A, but the quarter-over-quarter change shows the ratio fell 26.7% from 45.7x to 33.5x. The recent decline reduces the premium while the level still sits above the median, suggesting a valuation that is rich but cooling. That combination implies moderate risk: the stock is not cheap versus peers, but momentum in valuation is improving for a potential buyer. This metric generally supports the overall NEUTRAL verdict, as the P/E is neither a compelling bargain nor an extreme outlier relative to the sector.

Frequently Asked Questions

What does the P/E Ratio tell investors about BIO?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

How does BIO's P/E Ratio compare to its sector?

BIO's P/E Ratio of 33.5x compares to a Healthcare sector median of 28.5x, placing it in the 69th percentile.

Who are BIO's closest peers by P/E Ratio?

The closest Healthcare peers by P/E Ratio include: ABT (28.5x), CCLD (28.3x), ALGN (29.1x), AZN (27.0x), AMGN (24.7x).

📚

Learn More About P/E Ratio

DCF Valuation: How to Estimate What a Stock Is Actually Worth

Discounted Cash Flow is the most rigorous way to value a company. It's also the most misunderstood. Here's a plain-English walkthrough with a real example.

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.